| 6.6 |
19.7 |
GO:1903697 |
negative regulation of microvillus assembly(GO:1903697) |
| 5.1 |
20.3 |
GO:0032595 |
B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 5.0 |
40.3 |
GO:1902847 |
regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 4.9 |
19.6 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 4.3 |
12.9 |
GO:0010877 |
lipid transport involved in lipid storage(GO:0010877) |
| 4.0 |
16.0 |
GO:0048627 |
myoblast development(GO:0048627) |
| 3.8 |
15.1 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 3.6 |
14.5 |
GO:0098971 |
anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) |
| 3.5 |
13.8 |
GO:0002541 |
activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 3.4 |
27.4 |
GO:1902612 |
regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 3.3 |
13.4 |
GO:0061163 |
endoplasmic reticulum polarization(GO:0061163) actin filament bundle retrograde transport(GO:0061573) actin filament bundle distribution(GO:0070650) |
| 3.3 |
10.0 |
GO:1901069 |
guanosine-containing compound catabolic process(GO:1901069) |
| 3.3 |
13.1 |
GO:1903627 |
regulation of calcium-dependent ATPase activity(GO:1903610) negative regulation of calcium-dependent ATPase activity(GO:1903611) regulation of dUTP diphosphatase activity(GO:1903627) positive regulation of dUTP diphosphatase activity(GO:1903629) negative regulation of aminoacyl-tRNA ligase activity(GO:1903631) regulation of leucine-tRNA ligase activity(GO:1903633) negative regulation of leucine-tRNA ligase activity(GO:1903634) |
| 3.1 |
12.6 |
GO:0042377 |
menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 3.0 |
12.1 |
GO:0051410 |
detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
| 3.0 |
9.0 |
GO:1904692 |
positive regulation of type B pancreatic cell proliferation(GO:1904692) |
| 3.0 |
8.9 |
GO:0042137 |
sequestering of neurotransmitter(GO:0042137) |
| 2.9 |
14.7 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 2.9 |
8.8 |
GO:0071206 |
establishment of protein localization to juxtaparanode region of axon(GO:0071206) |
| 2.9 |
23.3 |
GO:0007412 |
axon target recognition(GO:0007412) |
| 2.9 |
11.5 |
GO:0043335 |
protein unfolding(GO:0043335) |
| 2.8 |
25.3 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) |
| 2.7 |
2.7 |
GO:1900449 |
regulation of glutamate receptor signaling pathway(GO:1900449) |
| 2.7 |
5.5 |
GO:0071676 |
negative regulation of mononuclear cell migration(GO:0071676) |
| 2.7 |
10.9 |
GO:1905069 |
allantois development(GO:1905069) |
| 2.7 |
8.0 |
GO:0031630 |
regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
| 2.6 |
7.9 |
GO:1990172 |
G-protein coupled receptor catabolic process(GO:1990172) |
| 2.6 |
15.9 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
| 2.6 |
2.6 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 2.6 |
10.5 |
GO:0031456 |
glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 2.6 |
34.0 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 2.6 |
7.8 |
GO:0031104 |
dendrite regeneration(GO:0031104) |
| 2.6 |
7.7 |
GO:0000412 |
histone peptidyl-prolyl isomerization(GO:0000412) |
| 2.5 |
5.1 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 2.5 |
7.6 |
GO:1903442 |
response to methylamine(GO:0036255) response to lipoic acid(GO:1903442) |
| 2.5 |
7.4 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 2.5 |
12.3 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 2.5 |
14.8 |
GO:0090027 |
negative regulation of monocyte chemotaxis(GO:0090027) |
| 2.4 |
12.2 |
GO:0032286 |
central nervous system myelin maintenance(GO:0032286) |
| 2.4 |
7.2 |
GO:0003147 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 2.4 |
19.1 |
GO:0070494 |
regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
| 2.4 |
14.2 |
GO:0060671 |
epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 2.3 |
7.0 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 2.3 |
18.8 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 2.3 |
4.6 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 2.3 |
16.2 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 2.3 |
4.6 |
GO:0010652 |
regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 2.3 |
6.8 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 2.2 |
9.0 |
GO:0070460 |
thyroid-stimulating hormone secretion(GO:0070460) regulation of thyroid-stimulating hormone secretion(GO:2000612) |
| 2.2 |
13.4 |
GO:0071874 |
cellular response to norepinephrine stimulus(GO:0071874) |
| 2.2 |
6.7 |
GO:0043000 |
Golgi to plasma membrane CFTR protein transport(GO:0043000) |
| 2.2 |
4.4 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 2.2 |
6.6 |
GO:0006742 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 2.2 |
8.7 |
GO:1900533 |
medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 2.2 |
10.8 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 2.2 |
2.2 |
GO:0021722 |
superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 2.2 |
2.2 |
GO:0055064 |
chloride ion homeostasis(GO:0055064) |
| 2.1 |
2.1 |
GO:1902430 |
negative regulation of beta-amyloid formation(GO:1902430) |
| 2.1 |
4.3 |
GO:0019448 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 2.1 |
8.5 |
GO:1990926 |
short-term synaptic potentiation(GO:1990926) |
| 2.1 |
10.5 |
GO:0015688 |
iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
| 2.1 |
8.3 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
| 2.1 |
12.4 |
GO:0006842 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 2.0 |
12.2 |
GO:0042819 |
pyridoxine metabolic process(GO:0008614) pyridoxine biosynthetic process(GO:0008615) vitamin B6 biosynthetic process(GO:0042819) |
| 2.0 |
6.0 |
GO:0070662 |
mast cell proliferation(GO:0070662) |
| 2.0 |
7.9 |
GO:1903892 |
negative regulation of ATF6-mediated unfolded protein response(GO:1903892) |
| 2.0 |
11.7 |
GO:1901910 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 1.9 |
3.9 |
GO:2000664 |
positive regulation of interleukin-5 secretion(GO:2000664) |
| 1.9 |
9.7 |
GO:0098904 |
regulation of AV node cell action potential(GO:0098904) |
| 1.9 |
1.9 |
GO:0006565 |
L-serine catabolic process(GO:0006565) |
| 1.9 |
7.7 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 1.9 |
15.4 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 1.9 |
5.8 |
GO:0098928 |
presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
| 1.9 |
9.6 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 1.9 |
7.6 |
GO:0031106 |
septin ring assembly(GO:0000921) septin ring organization(GO:0031106) |
| 1.9 |
5.7 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) |
| 1.9 |
5.6 |
GO:1904106 |
protein localization to microvillus(GO:1904106) |
| 1.9 |
16.9 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 1.9 |
5.6 |
GO:1903450 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 1.9 |
5.6 |
GO:0006147 |
guanine catabolic process(GO:0006147) |
| 1.8 |
33.0 |
GO:0032291 |
central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 1.8 |
3.6 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 1.8 |
3.6 |
GO:1902908 |
regulation of melanosome transport(GO:1902908) |
| 1.8 |
5.5 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 1.8 |
5.4 |
GO:0003330 |
regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 1.8 |
9.0 |
GO:0030070 |
insulin processing(GO:0030070) |
| 1.8 |
5.4 |
GO:0006173 |
dADP biosynthetic process(GO:0006173) |
| 1.8 |
8.9 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 1.8 |
3.6 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 1.8 |
3.6 |
GO:0060221 |
retinal rod cell differentiation(GO:0060221) |
| 1.8 |
5.3 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 1.8 |
1.8 |
GO:0061441 |
renal artery morphogenesis(GO:0061441) |
| 1.8 |
5.3 |
GO:0019303 |
D-ribose catabolic process(GO:0019303) |
| 1.7 |
7.0 |
GO:0019520 |
aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 1.7 |
10.5 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 1.7 |
12.2 |
GO:0030421 |
defecation(GO:0030421) |
| 1.7 |
1.7 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 1.7 |
6.9 |
GO:0009137 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 1.7 |
6.8 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 1.7 |
5.1 |
GO:0051939 |
gamma-aminobutyric acid import(GO:0051939) |
| 1.7 |
3.4 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 1.7 |
5.1 |
GO:1902598 |
creatine transport(GO:0015881) creatine transmembrane transport(GO:1902598) |
| 1.7 |
8.5 |
GO:1900738 |
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 1.7 |
6.8 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 1.7 |
5.1 |
GO:0097187 |
dentinogenesis(GO:0097187) |
| 1.7 |
3.4 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 1.7 |
26.8 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 1.7 |
5.0 |
GO:0019464 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 1.6 |
6.5 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 1.6 |
4.9 |
GO:2001287 |
negative regulation of caveolin-mediated endocytosis(GO:2001287) |
| 1.6 |
6.5 |
GO:1903568 |
negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 1.6 |
4.9 |
GO:1902722 |
positive regulation of prolactin secretion(GO:1902722) |
| 1.6 |
1.6 |
GO:0035249 |
synaptic transmission, glutamatergic(GO:0035249) |
| 1.6 |
6.5 |
GO:2001247 |
positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 1.6 |
6.4 |
GO:0072139 |
glomerular parietal epithelial cell differentiation(GO:0072139) |
| 1.6 |
4.8 |
GO:0036466 |
synaptic vesicle recycling via endosome(GO:0036466) |
| 1.6 |
6.4 |
GO:0032185 |
septin cytoskeleton organization(GO:0032185) |
| 1.6 |
11.2 |
GO:1903288 |
positive regulation of potassium ion import(GO:1903288) |
| 1.6 |
1.6 |
GO:0061289 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.6 |
8.0 |
GO:0045964 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 1.6 |
4.8 |
GO:0099538 |
synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 1.6 |
6.4 |
GO:0048817 |
negative regulation of hair follicle maturation(GO:0048817) |
| 1.6 |
23.7 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 1.6 |
22.0 |
GO:0034626 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 1.6 |
4.7 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 1.5 |
6.2 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 1.5 |
3.1 |
GO:1902744 |
negative regulation of lamellipodium assembly(GO:0010593) negative regulation of lamellipodium organization(GO:1902744) |
| 1.5 |
4.6 |
GO:2000588 |
positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
| 1.5 |
4.6 |
GO:0042489 |
negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
| 1.5 |
24.6 |
GO:0070777 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 1.5 |
13.7 |
GO:0018406 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 1.5 |
4.6 |
GO:1904956 |
regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
| 1.5 |
19.8 |
GO:0006578 |
amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
| 1.5 |
10.6 |
GO:0044791 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 1.5 |
9.1 |
GO:0016185 |
synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
| 1.5 |
6.0 |
GO:0014028 |
notochord formation(GO:0014028) |
| 1.5 |
22.6 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 1.5 |
4.5 |
GO:0033634 |
positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 1.5 |
7.5 |
GO:0051758 |
homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 1.5 |
19.4 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 1.5 |
7.4 |
GO:0061107 |
seminal vesicle development(GO:0061107) |
| 1.5 |
5.9 |
GO:0005986 |
sucrose biosynthetic process(GO:0005986) |
| 1.5 |
4.5 |
GO:0042660 |
positive regulation of cell fate specification(GO:0042660) |
| 1.5 |
5.9 |
GO:1902463 |
protein localization to cell leading edge(GO:1902463) |
| 1.5 |
4.4 |
GO:2000295 |
regulation of hydrogen peroxide catabolic process(GO:2000295) |
| 1.5 |
4.4 |
GO:0072720 |
response to dithiothreitol(GO:0072720) |
| 1.5 |
26.4 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 1.5 |
23.4 |
GO:0001766 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 1.5 |
19.0 |
GO:0042985 |
negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 1.4 |
8.6 |
GO:1902938 |
regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
| 1.4 |
18.7 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 1.4 |
7.2 |
GO:0009257 |
10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 1.4 |
28.6 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 1.4 |
10.0 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 1.4 |
5.7 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 1.4 |
19.9 |
GO:0046958 |
nonassociative learning(GO:0046958) |
| 1.4 |
5.7 |
GO:0042335 |
cuticle development(GO:0042335) |
| 1.4 |
9.9 |
GO:0031161 |
phosphatidylinositol catabolic process(GO:0031161) |
| 1.4 |
4.3 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 1.4 |
5.7 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 1.4 |
4.2 |
GO:0003095 |
pressure natriuresis(GO:0003095) |
| 1.4 |
5.6 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 1.4 |
14.1 |
GO:0018231 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 1.4 |
22.5 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 1.4 |
18.2 |
GO:0051388 |
positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 1.4 |
4.2 |
GO:0002415 |
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 1.4 |
1.4 |
GO:2000721 |
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
| 1.4 |
19.5 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 1.4 |
4.2 |
GO:0061536 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 1.4 |
4.2 |
GO:0070904 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 1.4 |
5.5 |
GO:0010900 |
negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 1.4 |
5.5 |
GO:0072023 |
thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
| 1.4 |
4.1 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 1.4 |
5.4 |
GO:1904529 |
regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 1.4 |
16.3 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 1.4 |
6.8 |
GO:1902896 |
terminal web assembly(GO:1902896) |
| 1.4 |
6.8 |
GO:0042369 |
vitamin D catabolic process(GO:0042369) |
| 1.3 |
8.1 |
GO:0033490 |
cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 1.3 |
5.4 |
GO:0097112 |
gamma-aminobutyric acid receptor clustering(GO:0097112) |
| 1.3 |
8.0 |
GO:0006574 |
valine catabolic process(GO:0006574) |
| 1.3 |
6.7 |
GO:1904566 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 1.3 |
4.0 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 1.3 |
21.3 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 1.3 |
18.7 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 1.3 |
4.0 |
GO:0009448 |
gamma-aminobutyric acid metabolic process(GO:0009448) |
| 1.3 |
2.7 |
GO:0001978 |
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 1.3 |
11.9 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 1.3 |
22.4 |
GO:0021681 |
cerebellar granular layer development(GO:0021681) |
| 1.3 |
2.6 |
GO:0036100 |
leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 1.3 |
3.9 |
GO:0090675 |
intermicrovillar adhesion(GO:0090675) |
| 1.3 |
3.9 |
GO:2000813 |
negative regulation of barbed-end actin filament capping(GO:2000813) |
| 1.3 |
3.9 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 1.3 |
9.1 |
GO:0043126 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 1.3 |
1.3 |
GO:0000494 |
box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
| 1.3 |
9.1 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 1.3 |
12.9 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 1.3 |
3.9 |
GO:1990736 |
positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
| 1.3 |
1.3 |
GO:0048022 |
negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 1.3 |
2.6 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 1.3 |
2.6 |
GO:0070253 |
somatostatin secretion(GO:0070253) |
| 1.3 |
6.4 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 1.3 |
6.4 |
GO:0070352 |
positive regulation of white fat cell proliferation(GO:0070352) |
| 1.3 |
3.8 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.3 |
1.3 |
GO:0036090 |
cleavage furrow ingression(GO:0036090) |
| 1.3 |
3.8 |
GO:1902996 |
regulation of neurofibrillary tangle assembly(GO:1902996) |
| 1.3 |
1.3 |
GO:0002590 |
regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 1.3 |
3.8 |
GO:0006589 |
octopamine biosynthetic process(GO:0006589) octopamine metabolic process(GO:0046333) |
| 1.3 |
15.1 |
GO:0023041 |
neuronal signal transduction(GO:0023041) |
| 1.3 |
8.8 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 1.3 |
5.0 |
GO:0048073 |
regulation of eye pigmentation(GO:0048073) |
| 1.2 |
2.5 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 1.2 |
16.2 |
GO:0015705 |
iodide transport(GO:0015705) |
| 1.2 |
6.2 |
GO:0046947 |
hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 1.2 |
3.7 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 1.2 |
3.7 |
GO:0036111 |
very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 1.2 |
16.0 |
GO:0046940 |
nucleoside monophosphate phosphorylation(GO:0046940) |
| 1.2 |
23.3 |
GO:0002138 |
retinoic acid biosynthetic process(GO:0002138) |
| 1.2 |
2.5 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 1.2 |
3.7 |
GO:0008057 |
eye pigment granule organization(GO:0008057) |
| 1.2 |
3.7 |
GO:1990641 |
response to iron ion starvation(GO:1990641) |
| 1.2 |
24.4 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 1.2 |
17.1 |
GO:1902669 |
positive regulation of axon guidance(GO:1902669) |
| 1.2 |
9.7 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 1.2 |
14.6 |
GO:0052696 |
flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 1.2 |
18.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 1.2 |
8.4 |
GO:0060455 |
negative regulation of gastric acid secretion(GO:0060455) |
| 1.2 |
6.0 |
GO:1902473 |
regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
| 1.2 |
7.2 |
GO:0038016 |
insulin receptor internalization(GO:0038016) |
| 1.2 |
4.8 |
GO:0035498 |
carnosine metabolic process(GO:0035498) |
| 1.2 |
3.6 |
GO:0071503 |
response to heparin(GO:0071503) |
| 1.2 |
10.8 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 1.2 |
3.6 |
GO:0031247 |
actin rod assembly(GO:0031247) |
| 1.2 |
4.8 |
GO:0042450 |
arginine biosynthetic process via ornithine(GO:0042450) |
| 1.2 |
2.4 |
GO:0097695 |
establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) |
| 1.2 |
19.1 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 1.2 |
2.4 |
GO:0032304 |
negative regulation of icosanoid secretion(GO:0032304) |
| 1.2 |
2.4 |
GO:1901491 |
negative regulation of lymphangiogenesis(GO:1901491) |
| 1.2 |
13.0 |
GO:2000582 |
regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 1.2 |
3.5 |
GO:0031291 |
Ran protein signal transduction(GO:0031291) |
| 1.2 |
8.2 |
GO:0032380 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 1.2 |
4.7 |
GO:1990569 |
UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
| 1.2 |
3.5 |
GO:0006683 |
galactosylceramide catabolic process(GO:0006683) |
| 1.2 |
1.2 |
GO:0016487 |
sesquiterpenoid metabolic process(GO:0006714) sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
| 1.2 |
4.6 |
GO:0061092 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 1.2 |
12.7 |
GO:0010739 |
positive regulation of protein kinase A signaling(GO:0010739) |
| 1.2 |
2.3 |
GO:0009183 |
purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 1.2 |
16.1 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 1.1 |
1.1 |
GO:0072174 |
metanephric tubule formation(GO:0072174) |
| 1.1 |
6.9 |
GO:0070101 |
positive regulation of chemokine-mediated signaling pathway(GO:0070101) |
| 1.1 |
12.5 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 1.1 |
15.9 |
GO:0003096 |
renal sodium ion transport(GO:0003096) |
| 1.1 |
5.7 |
GO:2000969 |
positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 1.1 |
10.1 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 1.1 |
20.1 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 1.1 |
2.2 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 1.1 |
6.7 |
GO:0071265 |
amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
| 1.1 |
65.6 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 1.1 |
1.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 1.1 |
3.3 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 1.1 |
1.1 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 1.1 |
1.1 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 1.1 |
5.5 |
GO:0046368 |
GDP-L-fucose metabolic process(GO:0046368) |
| 1.1 |
43.0 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 1.1 |
6.6 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
| 1.1 |
4.4 |
GO:0048104 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 1.1 |
6.5 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 1.1 |
8.7 |
GO:0006710 |
androgen catabolic process(GO:0006710) |
| 1.1 |
3.3 |
GO:0009085 |
lysine biosynthetic process(GO:0009085) lysine biosynthetic process via aminoadipic acid(GO:0019878) |
| 1.1 |
2.2 |
GO:0033591 |
response to L-ascorbic acid(GO:0033591) |
| 1.1 |
9.7 |
GO:0072093 |
metanephric renal vesicle formation(GO:0072093) |
| 1.1 |
4.3 |
GO:0070426 |
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 1.1 |
1.1 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 1.1 |
3.2 |
GO:0036486 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 1.1 |
6.5 |
GO:0002225 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
| 1.1 |
4.3 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 1.1 |
15.0 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 1.1 |
5.4 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 1.1 |
1.1 |
GO:0060179 |
male mating behavior(GO:0060179) |
| 1.1 |
2.1 |
GO:1903595 |
positive regulation of histamine secretion by mast cell(GO:1903595) |
| 1.1 |
13.8 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 1.1 |
1.1 |
GO:0008212 |
mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
| 1.1 |
3.2 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 1.1 |
2.1 |
GO:0002018 |
renin-angiotensin regulation of aldosterone production(GO:0002018) |
| 1.0 |
9.4 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 1.0 |
4.2 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 1.0 |
6.2 |
GO:0007497 |
posterior midgut development(GO:0007497) |
| 1.0 |
20.8 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 1.0 |
22.9 |
GO:0019800 |
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 1.0 |
1.0 |
GO:0010841 |
positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
| 1.0 |
1.0 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 1.0 |
50.8 |
GO:0008038 |
neuron recognition(GO:0008038) |
| 1.0 |
8.3 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 1.0 |
2.1 |
GO:0097477 |
lateral motor column neuron migration(GO:0097477) |
| 1.0 |
4.1 |
GO:0051794 |
catagen(GO:0042637) regulation of catagen(GO:0051794) positive regulation of catagen(GO:0051795) |
| 1.0 |
5.2 |
GO:0019323 |
pentose catabolic process(GO:0019323) |
| 1.0 |
1.0 |
GO:1904684 |
negative regulation of metalloendopeptidase activity(GO:1904684) |
| 1.0 |
3.1 |
GO:0030185 |
nitric oxide transport(GO:0030185) |
| 1.0 |
3.1 |
GO:1905033 |
positive regulation of actin filament-based movement(GO:1903116) positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903762) positive regulation of ventricular cardiac muscle cell action potential(GO:1903947) positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905026) positive regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905033) |
| 1.0 |
2.0 |
GO:0002424 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 1.0 |
3.0 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 1.0 |
4.1 |
GO:1990166 |
protein localization to site of double-strand break(GO:1990166) |
| 1.0 |
9.1 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 1.0 |
2.0 |
GO:0072603 |
interleukin-5 secretion(GO:0072603) regulation of interleukin-5 secretion(GO:2000662) |
| 1.0 |
5.0 |
GO:0042816 |
vitamin B6 metabolic process(GO:0042816) |
| 1.0 |
6.0 |
GO:0015853 |
adenine transport(GO:0015853) |
| 1.0 |
3.0 |
GO:0035425 |
autocrine signaling(GO:0035425) |
| 1.0 |
2.0 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 1.0 |
3.0 |
GO:0060739 |
mesenchymal-epithelial cell signaling involved in prostate gland development(GO:0060739) |
| 1.0 |
2.0 |
GO:0072244 |
metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 1.0 |
5.0 |
GO:1901254 |
modulation by host of viral RNA genome replication(GO:0044830) positive regulation of intracellular transport of viral material(GO:1901254) |
| 1.0 |
7.0 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 1.0 |
9.0 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 1.0 |
1.0 |
GO:2000171 |
negative regulation of dendrite development(GO:2000171) |
| 1.0 |
1.0 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 1.0 |
2.0 |
GO:0006540 |
glutamate decarboxylation to succinate(GO:0006540) |
| 1.0 |
5.0 |
GO:0035544 |
negative regulation of SNARE complex assembly(GO:0035544) |
| 1.0 |
1.0 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 1.0 |
10.9 |
GO:0015691 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 1.0 |
4.0 |
GO:0072526 |
pyridine-containing compound catabolic process(GO:0072526) |
| 1.0 |
15.8 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 1.0 |
2.0 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 1.0 |
7.9 |
GO:0072502 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 1.0 |
3.0 |
GO:0046081 |
dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
| 1.0 |
4.9 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 1.0 |
14.7 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 1.0 |
3.9 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 1.0 |
6.8 |
GO:1903899 |
positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 1.0 |
16.6 |
GO:0048846 |
axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
| 1.0 |
5.9 |
GO:0060414 |
aorta smooth muscle tissue morphogenesis(GO:0060414) |
| 1.0 |
2.9 |
GO:0009436 |
glyoxylate catabolic process(GO:0009436) |
| 1.0 |
2.9 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 1.0 |
1.9 |
GO:2000584 |
regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000583) negative regulation of platelet-derived growth factor receptor-alpha signaling pathway(GO:2000584) |
| 1.0 |
1.9 |
GO:1904204 |
regulation of skeletal muscle hypertrophy(GO:1904204) |
| 1.0 |
4.8 |
GO:0036515 |
serotonergic neuron axon guidance(GO:0036515) |
| 1.0 |
8.6 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 1.0 |
3.8 |
GO:0046440 |
L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 1.0 |
16.2 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 1.0 |
1.9 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 1.0 |
5.7 |
GO:0050893 |
sensory processing(GO:0050893) |
| 1.0 |
1.9 |
GO:0048371 |
lateral mesodermal cell differentiation(GO:0048371) |
| 1.0 |
1.9 |
GO:0010749 |
regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.9 |
0.9 |
GO:0010726 |
positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.9 |
2.8 |
GO:0051414 |
response to cortisol(GO:0051414) |
| 0.9 |
2.8 |
GO:0071314 |
cellular response to cocaine(GO:0071314) |
| 0.9 |
1.9 |
GO:2000118 |
regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.9 |
17.9 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.9 |
0.9 |
GO:0060738 |
epithelial-mesenchymal signaling involved in prostate gland development(GO:0060738) |
| 0.9 |
5.6 |
GO:0060482 |
lobar bronchus development(GO:0060482) |
| 0.9 |
8.4 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
| 0.9 |
3.8 |
GO:0010902 |
positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
| 0.9 |
2.8 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.9 |
4.7 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.9 |
3.7 |
GO:0006781 |
succinyl-CoA pathway(GO:0006781) |
| 0.9 |
4.6 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.9 |
9.3 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.9 |
3.7 |
GO:0097460 |
ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
| 0.9 |
2.8 |
GO:0042727 |
flavin-containing compound biosynthetic process(GO:0042727) |
| 0.9 |
0.9 |
GO:0016102 |
diterpenoid biosynthetic process(GO:0016102) |
| 0.9 |
7.4 |
GO:2000823 |
regulation of androgen receptor activity(GO:2000823) |
| 0.9 |
20.3 |
GO:1903830 |
magnesium ion transmembrane transport(GO:1903830) |
| 0.9 |
5.5 |
GO:0098746 |
fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.9 |
2.7 |
GO:2000560 |
CD24 biosynthetic process(GO:0035724) activation of meiosis involved in egg activation(GO:0060466) negative regulation of monocyte extravasation(GO:2000438) regulation of CD24 biosynthetic process(GO:2000559) positive regulation of CD24 biosynthetic process(GO:2000560) |
| 0.9 |
0.9 |
GO:0060406 |
positive regulation of penile erection(GO:0060406) |
| 0.9 |
2.7 |
GO:0051877 |
pigment granule aggregation in cell center(GO:0051877) |
| 0.9 |
18.0 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.9 |
4.5 |
GO:0019087 |
transformation of host cell by virus(GO:0019087) |
| 0.9 |
4.5 |
GO:0001971 |
negative regulation of activation of membrane attack complex(GO:0001971) |
| 0.9 |
2.7 |
GO:1990519 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.9 |
2.7 |
GO:0050760 |
negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.9 |
2.7 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.9 |
2.7 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.9 |
1.8 |
GO:1900244 |
positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle transport(GO:1902805) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.9 |
3.6 |
GO:0009258 |
10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.9 |
0.9 |
GO:0009397 |
folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.9 |
4.4 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.9 |
2.7 |
GO:1904578 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.9 |
4.4 |
GO:0032425 |
positive regulation of mismatch repair(GO:0032425) |
| 0.9 |
6.2 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.9 |
10.5 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.9 |
12.3 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.9 |
0.9 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.9 |
4.4 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.9 |
6.1 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.9 |
1.7 |
GO:0016999 |
antibiotic metabolic process(GO:0016999) |
| 0.9 |
4.4 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.9 |
7.8 |
GO:0050703 |
interleukin-1 alpha secretion(GO:0050703) |
| 0.9 |
13.1 |
GO:0097499 |
protein localization to nonmotile primary cilium(GO:0097499) |
| 0.9 |
4.3 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.9 |
0.9 |
GO:0045900 |
negative regulation of translational elongation(GO:0045900) |
| 0.9 |
8.7 |
GO:0042044 |
fluid transport(GO:0042044) |
| 0.9 |
6.0 |
GO:0021940 |
positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
| 0.9 |
3.4 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.9 |
8.6 |
GO:0006552 |
leucine catabolic process(GO:0006552) |
| 0.9 |
3.4 |
GO:0052651 |
monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.9 |
0.9 |
GO:0060435 |
bronchiole development(GO:0060435) |
| 0.9 |
6.9 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.9 |
4.3 |
GO:0003025 |
regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.9 |
1.7 |
GO:0003099 |
positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.9 |
5.1 |
GO:0035502 |
metanephric part of ureteric bud development(GO:0035502) |
| 0.9 |
6.8 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.8 |
2.5 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) |
| 0.8 |
7.6 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.8 |
0.8 |
GO:0061518 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
| 0.8 |
0.8 |
GO:1902957 |
negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
| 0.8 |
1.7 |
GO:0006704 |
glucocorticoid biosynthetic process(GO:0006704) |
| 0.8 |
5.1 |
GO:0002329 |
pre-B cell differentiation(GO:0002329) |
| 0.8 |
16.0 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.8 |
10.1 |
GO:0033629 |
negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 0.8 |
32.6 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.8 |
0.8 |
GO:0006533 |
aspartate catabolic process(GO:0006533) |
| 0.8 |
5.8 |
GO:0097327 |
response to antineoplastic agent(GO:0097327) |
| 0.8 |
2.5 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.8 |
7.5 |
GO:2000544 |
cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
| 0.8 |
2.5 |
GO:0035445 |
borate transmembrane transport(GO:0035445) borate transport(GO:0046713) |
| 0.8 |
19.8 |
GO:0006590 |
thyroid hormone generation(GO:0006590) |
| 0.8 |
1.6 |
GO:0051167 |
glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
| 0.8 |
2.5 |
GO:0038172 |
interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.8 |
1.6 |
GO:0018312 |
peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.8 |
2.5 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.8 |
5.7 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.8 |
4.1 |
GO:0070649 |
formin-nucleated actin cable assembly(GO:0070649) |
| 0.8 |
7.4 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.8 |
13.1 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.8 |
1.6 |
GO:0010899 |
regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 0.8 |
0.8 |
GO:2000182 |
regulation of progesterone biosynthetic process(GO:2000182) |
| 0.8 |
6.5 |
GO:0097503 |
sialylation(GO:0097503) |
| 0.8 |
4.9 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.8 |
14.6 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.8 |
1.6 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.8 |
3.2 |
GO:0016062 |
adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.8 |
2.4 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.8 |
2.4 |
GO:1905204 |
regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.8 |
5.6 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.8 |
5.6 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.8 |
3.2 |
GO:0036058 |
filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.8 |
2.4 |
GO:1903015 |
regulation of exo-alpha-sialidase activity(GO:1903015) |
| 0.8 |
4.0 |
GO:1903061 |
positive regulation of protein lipidation(GO:1903061) |
| 0.8 |
0.8 |
GO:0048793 |
pronephros development(GO:0048793) |
| 0.8 |
2.4 |
GO:0060086 |
circadian temperature homeostasis(GO:0060086) |
| 0.8 |
7.1 |
GO:0045836 |
positive regulation of meiotic nuclear division(GO:0045836) |
| 0.8 |
3.2 |
GO:1904117 |
response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.8 |
6.3 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.8 |
5.5 |
GO:0046086 |
adenosine biosynthetic process(GO:0046086) |
| 0.8 |
3.1 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.8 |
0.8 |
GO:0045196 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.8 |
0.8 |
GO:0036006 |
response to macrophage colony-stimulating factor(GO:0036005) cellular response to macrophage colony-stimulating factor stimulus(GO:0036006) |
| 0.8 |
3.1 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.8 |
2.3 |
GO:0035565 |
regulation of pronephros size(GO:0035565) |
| 0.8 |
0.8 |
GO:0071907 |
determination of digestive tract left/right asymmetry(GO:0071907) |
| 0.8 |
3.1 |
GO:0071418 |
cellular response to amine stimulus(GO:0071418) |
| 0.8 |
3.1 |
GO:1900019 |
regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.8 |
0.8 |
GO:0036510 |
trimming of terminal mannose on C branch(GO:0036510) |
| 0.8 |
3.1 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.8 |
4.6 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.8 |
2.3 |
GO:1902766 |
skeletal muscle satellite cell migration(GO:1902766) |
| 0.8 |
1.5 |
GO:0035962 |
response to interleukin-13(GO:0035962) |
| 0.8 |
0.8 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.8 |
4.5 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.8 |
1.5 |
GO:0090119 |
vesicle-mediated cholesterol transport(GO:0090119) |
| 0.8 |
4.5 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.8 |
9.0 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.8 |
3.8 |
GO:1903613 |
regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
| 0.8 |
6.8 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.7 |
6.7 |
GO:0071500 |
cellular response to nitrosative stress(GO:0071500) |
| 0.7 |
2.2 |
GO:0046108 |
uridine metabolic process(GO:0046108) |
| 0.7 |
1.5 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.7 |
5.2 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.7 |
7.5 |
GO:0021633 |
optic nerve structural organization(GO:0021633) |
| 0.7 |
1.5 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.7 |
3.0 |
GO:0003406 |
retinal pigment epithelium development(GO:0003406) |
| 0.7 |
8.9 |
GO:0046519 |
sphingoid metabolic process(GO:0046519) |
| 0.7 |
10.4 |
GO:0035878 |
nail development(GO:0035878) |
| 0.7 |
3.7 |
GO:1901350 |
cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 0.7 |
1.5 |
GO:2000078 |
positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.7 |
0.7 |
GO:0099612 |
protein localization to axon(GO:0099612) |
| 0.7 |
3.7 |
GO:0033578 |
protein glycosylation in Golgi(GO:0033578) |
| 0.7 |
1.5 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.7 |
0.7 |
GO:0070563 |
negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
| 0.7 |
1.5 |
GO:0071283 |
cellular response to iron(III) ion(GO:0071283) |
| 0.7 |
2.2 |
GO:0061589 |
calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.7 |
3.7 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.7 |
3.6 |
GO:0099558 |
maintenance of synapse structure(GO:0099558) |
| 0.7 |
9.5 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.7 |
2.2 |
GO:0097070 |
ductus arteriosus closure(GO:0097070) |
| 0.7 |
8.7 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.7 |
22.5 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
| 0.7 |
2.2 |
GO:0001994 |
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
| 0.7 |
6.5 |
GO:0007185 |
transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.7 |
31.2 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.7 |
9.4 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.7 |
1.4 |
GO:1902024 |
histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
| 0.7 |
7.2 |
GO:0042428 |
serotonin metabolic process(GO:0042428) |
| 0.7 |
7.2 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.7 |
0.7 |
GO:0044205 |
'de novo' UMP biosynthetic process(GO:0044205) |
| 0.7 |
10.1 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.7 |
4.3 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.7 |
1.4 |
GO:0022615 |
protein to membrane docking(GO:0022615) |
| 0.7 |
2.9 |
GO:0060168 |
positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.7 |
0.7 |
GO:0033076 |
isoquinoline alkaloid metabolic process(GO:0033076) |
| 0.7 |
2.2 |
GO:0050915 |
sensory perception of sour taste(GO:0050915) |
| 0.7 |
12.2 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.7 |
5.0 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.7 |
7.2 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.7 |
10.0 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.7 |
14.2 |
GO:0036109 |
alpha-linolenic acid metabolic process(GO:0036109) |
| 0.7 |
2.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.7 |
2.8 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.7 |
6.4 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.7 |
8.5 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
| 0.7 |
3.5 |
GO:0045113 |
regulation of integrin biosynthetic process(GO:0045113) |
| 0.7 |
2.1 |
GO:0070682 |
proteasome regulatory particle assembly(GO:0070682) |
| 0.7 |
4.9 |
GO:1902019 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.7 |
0.7 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.7 |
2.1 |
GO:0036323 |
vascular endothelial growth factor receptor-1 signaling pathway(GO:0036323) |
| 0.7 |
0.7 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.7 |
4.2 |
GO:1903385 |
regulation of homophilic cell adhesion(GO:1903385) |
| 0.7 |
3.5 |
GO:0048168 |
regulation of neuronal synaptic plasticity(GO:0048168) |
| 0.7 |
2.1 |
GO:1901291 |
negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
| 0.7 |
6.3 |
GO:0000395 |
mRNA 5'-splice site recognition(GO:0000395) |
| 0.7 |
3.5 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.7 |
14.0 |
GO:0031915 |
positive regulation of synaptic plasticity(GO:0031915) |
| 0.7 |
0.7 |
GO:0071422 |
succinate transport(GO:0015744) succinate transmembrane transport(GO:0071422) |
| 0.7 |
7.7 |
GO:0051932 |
synaptic transmission, GABAergic(GO:0051932) |
| 0.7 |
34.1 |
GO:1903861 |
positive regulation of dendrite extension(GO:1903861) |
| 0.7 |
4.9 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.7 |
3.5 |
GO:0044154 |
histone H3-K14 acetylation(GO:0044154) |
| 0.7 |
0.7 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.7 |
2.8 |
GO:0034553 |
respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
| 0.7 |
2.1 |
GO:0032917 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.7 |
1.4 |
GO:0045168 |
cell-cell signaling involved in cell fate commitment(GO:0045168) |
| 0.7 |
2.1 |
GO:0051807 |
evasion or tolerance of host immune response(GO:0020012) evasion or tolerance of host defense response(GO:0030682) evasion or tolerance by virus of host immune response(GO:0030683) evasion or tolerance of immune response of other organism involved in symbiotic interaction(GO:0051805) evasion or tolerance of defense response of other organism involved in symbiotic interaction(GO:0051807) |
| 0.7 |
4.8 |
GO:0060066 |
glial cell fate determination(GO:0007403) negative regulation of mitotic cell cycle, embryonic(GO:0045976) oviduct development(GO:0060066) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
| 0.7 |
32.8 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.7 |
4.8 |
GO:0098706 |
ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.7 |
2.0 |
GO:0045897 |
positive regulation of transcription during mitosis(GO:0045897) |
| 0.7 |
1.4 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.7 |
6.1 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.7 |
3.4 |
GO:0046167 |
glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.7 |
1.4 |
GO:0086100 |
endothelin receptor signaling pathway(GO:0086100) |
| 0.7 |
2.7 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.7 |
0.7 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
| 0.7 |
2.7 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.7 |
7.4 |
GO:0051599 |
response to hydrostatic pressure(GO:0051599) |
| 0.7 |
2.0 |
GO:2000381 |
negative regulation of mesoderm development(GO:2000381) |
| 0.7 |
4.0 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.7 |
4.7 |
GO:0060068 |
vagina development(GO:0060068) |
| 0.7 |
8.7 |
GO:0097107 |
postsynaptic density organization(GO:0097106) postsynaptic density assembly(GO:0097107) gephyrin clustering involved in postsynaptic density assembly(GO:0097116) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.7 |
0.7 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.7 |
6.0 |
GO:0055129 |
L-proline biosynthetic process(GO:0055129) |
| 0.7 |
9.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.7 |
11.9 |
GO:1901750 |
leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.7 |
31.5 |
GO:0048791 |
calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.7 |
3.3 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.7 |
15.1 |
GO:1901685 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.7 |
0.7 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.7 |
2.6 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.7 |
1.3 |
GO:0035790 |
platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
| 0.7 |
2.6 |
GO:1905071 |
occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
| 0.7 |
5.2 |
GO:1903748 |
negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.6 |
0.6 |
GO:0009256 |
10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.6 |
3.2 |
GO:0035021 |
negative regulation of Rac protein signal transduction(GO:0035021) |
| 0.6 |
8.4 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 0.6 |
1.9 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) |
| 0.6 |
0.6 |
GO:0044062 |
regulation of excretion(GO:0044062) |
| 0.6 |
1.3 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.6 |
10.9 |
GO:2000300 |
regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.6 |
2.6 |
GO:0070781 |
protein biotinylation(GO:0009305) response to biotin(GO:0070781) histone biotinylation(GO:0071110) |
| 0.6 |
2.6 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.6 |
3.2 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.6 |
1.9 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.6 |
1.9 |
GO:0017186 |
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.6 |
0.6 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.6 |
2.5 |
GO:0006617 |
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.6 |
5.1 |
GO:0060441 |
epithelial tube branching involved in lung morphogenesis(GO:0060441) |
| 0.6 |
0.6 |
GO:1902949 |
positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.6 |
1.9 |
GO:0090611 |
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 0.6 |
2.5 |
GO:0006408 |
snRNA export from nucleus(GO:0006408) |
| 0.6 |
13.9 |
GO:2000480 |
negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.6 |
2.5 |
GO:0048749 |
compound eye development(GO:0048749) |
| 0.6 |
0.6 |
GO:0060571 |
morphogenesis of an epithelial fold(GO:0060571) |
| 0.6 |
1.3 |
GO:0071284 |
cellular response to lead ion(GO:0071284) |
| 0.6 |
1.3 |
GO:1903441 |
protein localization to ciliary membrane(GO:1903441) |
| 0.6 |
1.3 |
GO:0001973 |
adenosine receptor signaling pathway(GO:0001973) |
| 0.6 |
2.5 |
GO:2000479 |
regulation of cAMP-dependent protein kinase activity(GO:2000479) |
| 0.6 |
2.5 |
GO:1900737 |
negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
| 0.6 |
5.0 |
GO:1904879 |
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
| 0.6 |
2.5 |
GO:0038194 |
thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.6 |
10.5 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.6 |
2.5 |
GO:0060686 |
negative regulation of prostatic bud formation(GO:0060686) |
| 0.6 |
1.9 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.6 |
1.2 |
GO:2000576 |
positive regulation of microtubule motor activity(GO:2000576) |
| 0.6 |
4.3 |
GO:0030516 |
regulation of axon extension(GO:0030516) |
| 0.6 |
2.5 |
GO:1900229 |
biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.6 |
1.2 |
GO:1903937 |
response to acrylamide(GO:1903937) |
| 0.6 |
4.3 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.6 |
1.8 |
GO:1904020 |
regulation of G-protein coupled receptor internalization(GO:1904020) |
| 0.6 |
1.2 |
GO:0016093 |
polyprenol metabolic process(GO:0016093) |
| 0.6 |
7.3 |
GO:0070560 |
protein secretion by platelet(GO:0070560) |
| 0.6 |
1.8 |
GO:0010641 |
positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
| 0.6 |
5.4 |
GO:0000101 |
sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
| 0.6 |
10.3 |
GO:1902222 |
L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.6 |
1.8 |
GO:0042424 |
catechol-containing compound catabolic process(GO:0019614) catecholamine catabolic process(GO:0042424) |
| 0.6 |
3.0 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.6 |
3.0 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.6 |
4.8 |
GO:0060081 |
membrane hyperpolarization(GO:0060081) |
| 0.6 |
2.4 |
GO:0070837 |
dehydroascorbic acid transport(GO:0070837) |
| 0.6 |
25.2 |
GO:0042026 |
protein refolding(GO:0042026) |
| 0.6 |
1.8 |
GO:1904864 |
regulation of beta-catenin-TCF complex assembly(GO:1904863) negative regulation of beta-catenin-TCF complex assembly(GO:1904864) |
| 0.6 |
1.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.6 |
4.8 |
GO:0036324 |
vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.6 |
2.4 |
GO:0034224 |
cellular response to zinc ion starvation(GO:0034224) |
| 0.6 |
5.4 |
GO:0031427 |
response to methotrexate(GO:0031427) |
| 0.6 |
1.2 |
GO:0031133 |
regulation of axon diameter(GO:0031133) |
| 0.6 |
13.6 |
GO:0050651 |
dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
| 0.6 |
1.2 |
GO:0018171 |
peptidyl-cysteine oxidation(GO:0018171) |
| 0.6 |
10.6 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.6 |
8.3 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.6 |
2.9 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.6 |
2.4 |
GO:0061762 |
CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.6 |
2.4 |
GO:0042415 |
norepinephrine metabolic process(GO:0042415) |
| 0.6 |
1.8 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.6 |
0.6 |
GO:0010269 |
response to selenium ion(GO:0010269) |
| 0.6 |
4.7 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.6 |
1.7 |
GO:2001311 |
lysobisphosphatidic acid metabolic process(GO:2001311) |
| 0.6 |
2.3 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.6 |
1.7 |
GO:0015800 |
acidic amino acid transport(GO:0015800) |
| 0.6 |
5.2 |
GO:0072178 |
nephric duct morphogenesis(GO:0072178) |
| 0.6 |
2.9 |
GO:0035750 |
protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.6 |
5.2 |
GO:1990834 |
response to odorant(GO:1990834) |
| 0.6 |
2.9 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.6 |
1.7 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.6 |
4.0 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.6 |
2.3 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
| 0.6 |
5.7 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.6 |
0.6 |
GO:1900223 |
positive regulation of beta-amyloid clearance(GO:1900223) |
| 0.6 |
4.0 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.6 |
0.6 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.6 |
13.7 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.6 |
2.3 |
GO:0043308 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.6 |
1.1 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.6 |
5.7 |
GO:2000253 |
positive regulation of feeding behavior(GO:2000253) |
| 0.6 |
2.3 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.6 |
48.2 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.6 |
1.1 |
GO:0015827 |
tryptophan transport(GO:0015827) |
| 0.6 |
1.7 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.6 |
26.4 |
GO:0099601 |
regulation of neurotransmitter receptor activity(GO:0099601) |
| 0.6 |
3.4 |
GO:0051597 |
response to methylmercury(GO:0051597) |
| 0.6 |
1.1 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.6 |
0.6 |
GO:0051097 |
negative regulation of helicase activity(GO:0051097) |
| 0.6 |
1.7 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.6 |
2.2 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.6 |
1.7 |
GO:0071140 |
resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
| 0.6 |
10.0 |
GO:0033197 |
response to vitamin E(GO:0033197) |
| 0.6 |
0.6 |
GO:0015801 |
aromatic amino acid transport(GO:0015801) |
| 0.6 |
1.7 |
GO:0019287 |
isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.6 |
1.1 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.6 |
2.2 |
GO:0061744 |
psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
| 0.5 |
6.0 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.5 |
2.2 |
GO:0097286 |
iron ion import(GO:0097286) |
| 0.5 |
3.3 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.5 |
1.6 |
GO:1900106 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.5 |
1.1 |
GO:0060426 |
lung vasculature development(GO:0060426) |
| 0.5 |
3.8 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.5 |
4.9 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.5 |
6.5 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.5 |
4.8 |
GO:0035754 |
B cell chemotaxis(GO:0035754) |
| 0.5 |
23.1 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.5 |
3.2 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.5 |
1.1 |
GO:0060029 |
convergent extension involved in organogenesis(GO:0060029) |
| 0.5 |
25.1 |
GO:0021762 |
substantia nigra development(GO:0021762) |
| 0.5 |
3.7 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.5 |
2.1 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.5 |
1.6 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.5 |
2.1 |
GO:0010430 |
fatty acid omega-oxidation(GO:0010430) |
| 0.5 |
2.6 |
GO:1903971 |
mammary gland fat development(GO:0060611) regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) regulation of response to macrophage colony-stimulating factor(GO:1903969) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) positive regulation of microglial cell migration(GO:1904141) |
| 0.5 |
0.5 |
GO:0071931 |
positive regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071931) |
| 0.5 |
5.3 |
GO:0030472 |
mitotic spindle organization in nucleus(GO:0030472) |
| 0.5 |
2.6 |
GO:0036119 |
response to platelet-derived growth factor(GO:0036119) |
| 0.5 |
1.6 |
GO:0044332 |
Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
| 0.5 |
2.1 |
GO:0042363 |
fat-soluble vitamin catabolic process(GO:0042363) |
| 0.5 |
5.3 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.5 |
4.7 |
GO:0010579 |
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.5 |
0.5 |
GO:1902595 |
regulation of DNA replication origin binding(GO:1902595) |
| 0.5 |
1.6 |
GO:0038109 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.5 |
2.1 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.5 |
4.7 |
GO:0030050 |
vesicle transport along actin filament(GO:0030050) |
| 0.5 |
5.2 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.5 |
28.1 |
GO:0046710 |
GDP metabolic process(GO:0046710) |
| 0.5 |
12.5 |
GO:0030277 |
maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.5 |
1.6 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.5 |
7.3 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 |
1.6 |
GO:0042573 |
retinoic acid metabolic process(GO:0042573) |
| 0.5 |
5.2 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.5 |
2.6 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.5 |
3.6 |
GO:0046618 |
drug export(GO:0046618) |
| 0.5 |
1.5 |
GO:0019322 |
pentose biosynthetic process(GO:0019322) |
| 0.5 |
1.0 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.5 |
1.5 |
GO:0070625 |
zymogen granule exocytosis(GO:0070625) |
| 0.5 |
5.1 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.5 |
3.1 |
GO:1905123 |
regulation of glucosylceramidase activity(GO:1905123) |
| 0.5 |
6.1 |
GO:0010912 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
| 0.5 |
3.6 |
GO:0072719 |
cellular response to cisplatin(GO:0072719) |
| 0.5 |
6.1 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.5 |
2.5 |
GO:1901529 |
positive regulation of anion channel activity(GO:1901529) |
| 0.5 |
11.1 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.5 |
1.5 |
GO:2000656 |
regulation of apolipoprotein binding(GO:2000656) negative regulation of apolipoprotein binding(GO:2000657) |
| 0.5 |
1.5 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.5 |
1.0 |
GO:0006311 |
meiotic gene conversion(GO:0006311) |
| 0.5 |
1.5 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 0.5 |
0.5 |
GO:0071878 |
negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
| 0.5 |
0.5 |
GO:0070900 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.5 |
4.9 |
GO:1902412 |
regulation of mitotic cytokinesis(GO:1902412) |
| 0.5 |
1.5 |
GO:0070902 |
mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 0.5 |
3.4 |
GO:0044331 |
cell-cell adhesion mediated by cadherin(GO:0044331) |
| 0.5 |
2.0 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.5 |
1.5 |
GO:1901388 |
regulation of transforming growth factor beta activation(GO:1901388) negative regulation of transforming growth factor beta activation(GO:1901389) |
| 0.5 |
3.9 |
GO:0097646 |
calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.5 |
7.8 |
GO:0019371 |
cyclooxygenase pathway(GO:0019371) |
| 0.5 |
2.0 |
GO:0006982 |
response to lipid hydroperoxide(GO:0006982) |
| 0.5 |
0.5 |
GO:0002118 |
aggressive behavior(GO:0002118) |
| 0.5 |
10.3 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.5 |
0.5 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.5 |
3.4 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.5 |
0.5 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.5 |
4.4 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.5 |
23.7 |
GO:0008542 |
visual learning(GO:0008542) |
| 0.5 |
0.5 |
GO:0070541 |
response to platinum ion(GO:0070541) |
| 0.5 |
0.5 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.5 |
2.4 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.5 |
26.0 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.5 |
2.4 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.5 |
8.2 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.5 |
3.4 |
GO:0034499 |
late endosome to Golgi transport(GO:0034499) |
| 0.5 |
6.2 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.5 |
2.4 |
GO:1900452 |
regulation of long term synaptic depression(GO:1900452) |
| 0.5 |
1.4 |
GO:0044278 |
cell wall disruption in other organism(GO:0044278) |
| 0.5 |
3.8 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.5 |
7.2 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.5 |
2.9 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.5 |
2.4 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.5 |
2.9 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.5 |
3.8 |
GO:0060160 |
negative regulation of dopamine receptor signaling pathway(GO:0060160) |
| 0.5 |
2.4 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.5 |
0.5 |
GO:0055075 |
potassium ion homeostasis(GO:0055075) |
| 0.5 |
1.4 |
GO:0071468 |
cellular response to acidic pH(GO:0071468) |
| 0.5 |
10.3 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.5 |
2.8 |
GO:0010615 |
positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
| 0.5 |
6.5 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.5 |
1.9 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.5 |
2.3 |
GO:0097052 |
L-kynurenine metabolic process(GO:0097052) |
| 0.5 |
0.5 |
GO:2000777 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 0.5 |
2.3 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.5 |
11.0 |
GO:0050427 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.5 |
0.9 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.5 |
0.9 |
GO:0033594 |
response to hydroxyisoflavone(GO:0033594) |
| 0.5 |
0.5 |
GO:0046416 |
D-amino acid metabolic process(GO:0046416) |
| 0.5 |
10.9 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.5 |
4.5 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.5 |
13.2 |
GO:0055078 |
sodium ion homeostasis(GO:0055078) |
| 0.5 |
3.6 |
GO:1900827 |
maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.5 |
2.3 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.5 |
2.7 |
GO:0034316 |
negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.5 |
1.4 |
GO:0002314 |
germinal center B cell differentiation(GO:0002314) |
| 0.5 |
2.7 |
GO:0015680 |
intracellular copper ion transport(GO:0015680) |
| 0.5 |
2.3 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
| 0.4 |
2.7 |
GO:0050771 |
negative regulation of axonogenesis(GO:0050771) |
| 0.4 |
8.5 |
GO:0042249 |
establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.4 |
4.9 |
GO:0035437 |
maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.4 |
4.0 |
GO:0014829 |
vascular smooth muscle contraction(GO:0014829) |
| 0.4 |
2.2 |
GO:0019605 |
butyrate metabolic process(GO:0019605) |
| 0.4 |
1.8 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.4 |
1.8 |
GO:0006393 |
termination of mitochondrial transcription(GO:0006393) |
| 0.4 |
18.1 |
GO:0099643 |
neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
| 0.4 |
0.9 |
GO:1901857 |
positive regulation of cellular respiration(GO:1901857) |
| 0.4 |
2.2 |
GO:2000074 |
regulation of type B pancreatic cell development(GO:2000074) |
| 0.4 |
1.7 |
GO:1902283 |
negative regulation of primary amine oxidase activity(GO:1902283) |
| 0.4 |
3.1 |
GO:1902731 |
negative regulation of chondrocyte proliferation(GO:1902731) |
| 0.4 |
2.6 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.4 |
1.7 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.4 |
4.8 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.4 |
6.5 |
GO:0046928 |
regulation of neurotransmitter secretion(GO:0046928) |
| 0.4 |
3.9 |
GO:0035810 |
positive regulation of urine volume(GO:0035810) |
| 0.4 |
8.6 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.4 |
5.6 |
GO:0010719 |
negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.4 |
3.9 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) |
| 0.4 |
2.2 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.4 |
2.6 |
GO:2000661 |
positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.4 |
1.3 |
GO:1990414 |
replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.4 |
3.0 |
GO:0099566 |
regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.4 |
1.7 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.4 |
3.4 |
GO:0030309 |
poly-N-acetyllactosamine metabolic process(GO:0030309) |
| 0.4 |
1.7 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.4 |
0.4 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.4 |
1.3 |
GO:1900041 |
negative regulation of interleukin-2 secretion(GO:1900041) |
| 0.4 |
1.3 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.4 |
4.7 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.4 |
3.0 |
GO:0051386 |
regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
| 0.4 |
2.1 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.4 |
3.8 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.4 |
4.2 |
GO:0015840 |
urea transport(GO:0015840) |
| 0.4 |
5.5 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.4 |
2.1 |
GO:1901202 |
negative regulation of extracellular matrix assembly(GO:1901202) |
| 0.4 |
1.3 |
GO:0002426 |
immunoglobulin production in mucosal tissue(GO:0002426) |
| 0.4 |
1.7 |
GO:0008612 |
peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.4 |
3.8 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 |
18.9 |
GO:0007588 |
excretion(GO:0007588) |
| 0.4 |
2.5 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.4 |
4.2 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.4 |
1.3 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.4 |
0.4 |
GO:0018364 |
peptidyl-glutamine methylation(GO:0018364) |
| 0.4 |
1.2 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.4 |
0.4 |
GO:0097484 |
dendrite extension(GO:0097484) |
| 0.4 |
1.7 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.4 |
12.8 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.4 |
1.2 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.4 |
1.6 |
GO:0014848 |
urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.4 |
3.7 |
GO:0042073 |
intraciliary transport(GO:0042073) |
| 0.4 |
2.5 |
GO:1902993 |
positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
| 0.4 |
5.3 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.4 |
1.2 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.4 |
2.0 |
GO:1900194 |
negative regulation of oocyte maturation(GO:1900194) |
| 0.4 |
1.2 |
GO:2000503 |
positive regulation of natural killer cell chemotaxis(GO:2000503) |
| 0.4 |
0.8 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.4 |
0.8 |
GO:0099590 |
neurotransmitter receptor internalization(GO:0099590) |
| 0.4 |
2.8 |
GO:0021859 |
pyramidal neuron differentiation(GO:0021859) |
| 0.4 |
5.7 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.4 |
1.2 |
GO:0010519 |
negative regulation of phospholipase activity(GO:0010519) |
| 0.4 |
0.8 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.4 |
1.2 |
GO:0060633 |
negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) |
| 0.4 |
15.7 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
| 0.4 |
0.4 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.4 |
11.3 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.4 |
7.2 |
GO:0060732 |
positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.4 |
1.2 |
GO:0016267 |
O-glycan processing, core 1(GO:0016267) |
| 0.4 |
10.4 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.4 |
0.8 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
| 0.4 |
6.8 |
GO:0086015 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) |
| 0.4 |
1.6 |
GO:0010286 |
heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 0.4 |
0.4 |
GO:0051182 |
coenzyme transport(GO:0051182) |
| 0.4 |
1.6 |
GO:0060474 |
positive regulation of sperm motility involved in capacitation(GO:0060474) |
| 0.4 |
2.8 |
GO:0018197 |
peptidyl-aspartic acid modification(GO:0018197) |
| 0.4 |
1.6 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.4 |
1.2 |
GO:0048213 |
Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.4 |
4.7 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.4 |
0.4 |
GO:0070309 |
lens fiber cell morphogenesis(GO:0070309) |
| 0.4 |
3.1 |
GO:1901660 |
calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.4 |
1.6 |
GO:0032417 |
regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.4 |
1.2 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.4 |
2.3 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.4 |
2.7 |
GO:0046465 |
dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
| 0.4 |
3.1 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.4 |
0.4 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.4 |
12.8 |
GO:0035235 |
ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.4 |
1.2 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.4 |
5.4 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.4 |
1.1 |
GO:0007182 |
common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.4 |
10.3 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.4 |
3.4 |
GO:0007196 |
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
| 0.4 |
1.1 |
GO:0086048 |
membrane depolarization during bundle of His cell action potential(GO:0086048) |
| 0.4 |
3.1 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.4 |
2.3 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.4 |
1.1 |
GO:1903576 |
response to L-arginine(GO:1903576) |
| 0.4 |
1.5 |
GO:1900148 |
Schwann cell proliferation involved in axon regeneration(GO:0014011) negative regulation of Schwann cell migration(GO:1900148) regulation of Schwann cell proliferation involved in axon regeneration(GO:1905044) negative regulation of Schwann cell proliferation involved in axon regeneration(GO:1905045) |
| 0.4 |
3.4 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.4 |
16.4 |
GO:0006904 |
vesicle docking involved in exocytosis(GO:0006904) |
| 0.4 |
3.8 |
GO:0051084 |
'de novo' posttranslational protein folding(GO:0051084) |
| 0.4 |
1.1 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.4 |
1.5 |
GO:0051904 |
pigment granule transport(GO:0051904) |
| 0.4 |
4.5 |
GO:0051988 |
regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.4 |
1.9 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.4 |
2.3 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.4 |
9.0 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.4 |
1.9 |
GO:1900110 |
negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.4 |
10.5 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.4 |
4.1 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.4 |
2.2 |
GO:0090481 |
pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 0.4 |
0.7 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.4 |
5.2 |
GO:0033145 |
positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
| 0.4 |
5.2 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.4 |
3.3 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.4 |
1.1 |
GO:1905053 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.4 |
0.4 |
GO:0035759 |
mesangial cell-matrix adhesion(GO:0035759) |
| 0.4 |
2.2 |
GO:1904781 |
positive regulation of protein localization to centrosome(GO:1904781) |
| 0.4 |
1.1 |
GO:0034443 |
regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
| 0.4 |
1.5 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.4 |
1.1 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.4 |
1.1 |
GO:1903232 |
melanosome assembly(GO:1903232) |
| 0.4 |
1.5 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.4 |
5.1 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.4 |
1.4 |
GO:0051127 |
positive regulation of actin nucleation(GO:0051127) |
| 0.4 |
1.4 |
GO:1904977 |
lymphatic endothelial cell migration(GO:1904977) |
| 0.4 |
0.7 |
GO:0098935 |
dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
| 0.4 |
2.9 |
GO:0097205 |
renal filtration(GO:0097205) |
| 0.4 |
1.4 |
GO:1902528 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.4 |
0.7 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 0.4 |
1.1 |
GO:0007225 |
patched ligand maturation(GO:0007225) signal maturation(GO:0035638) |
| 0.4 |
3.6 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 0.4 |
3.9 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.4 |
2.5 |
GO:0097428 |
protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.4 |
0.7 |
GO:0046356 |
acetyl-CoA catabolic process(GO:0046356) |
| 0.4 |
3.9 |
GO:0000160 |
phosphorelay signal transduction system(GO:0000160) |
| 0.4 |
1.8 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.4 |
9.9 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.4 |
16.5 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.4 |
1.1 |
GO:1901679 |
nucleotide transmembrane transport(GO:1901679) |
| 0.3 |
1.4 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.3 |
2.1 |
GO:0001714 |
endodermal cell fate specification(GO:0001714) |
| 0.3 |
7.3 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.3 |
3.8 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.3 |
1.0 |
GO:1903774 |
positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 0.3 |
65.3 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.3 |
0.7 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.3 |
1.4 |
GO:1902269 |
positive regulation of polyamine transmembrane transport(GO:1902269) |
| 0.3 |
7.2 |
GO:0061462 |
protein localization to lysosome(GO:0061462) |
| 0.3 |
1.0 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.3 |
1.7 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.3 |
1.7 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) |
| 0.3 |
3.4 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.3 |
3.8 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.3 |
4.1 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.3 |
2.0 |
GO:1903381 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.3 |
0.7 |
GO:0010193 |
response to ozone(GO:0010193) |
| 0.3 |
1.7 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.3 |
0.7 |
GO:0001964 |
startle response(GO:0001964) |
| 0.3 |
2.7 |
GO:0051005 |
negative regulation of lipoprotein lipase activity(GO:0051005) |
| 0.3 |
2.3 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.3 |
0.7 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.3 |
8.4 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.3 |
9.7 |
GO:0007416 |
synapse assembly(GO:0007416) |
| 0.3 |
2.7 |
GO:0090160 |
Golgi to lysosome transport(GO:0090160) |
| 0.3 |
3.0 |
GO:0070189 |
kynurenine metabolic process(GO:0070189) |
| 0.3 |
1.0 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.3 |
7.0 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.3 |
3.0 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.3 |
2.6 |
GO:0031529 |
ruffle organization(GO:0031529) |
| 0.3 |
4.6 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.3 |
1.3 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.3 |
1.0 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.3 |
3.0 |
GO:0042402 |
cellular biogenic amine catabolic process(GO:0042402) |
| 0.3 |
3.3 |
GO:0098703 |
calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.3 |
0.3 |
GO:0044335 |
canonical Wnt signaling pathway involved in neural crest cell differentiation(GO:0044335) |
| 0.3 |
2.6 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.3 |
3.6 |
GO:0038007 |
netrin-activated signaling pathway(GO:0038007) |
| 0.3 |
2.0 |
GO:0043129 |
surfactant homeostasis(GO:0043129) |
| 0.3 |
4.9 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.3 |
6.2 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.3 |
2.6 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.3 |
3.6 |
GO:0035694 |
mitochondrial protein catabolic process(GO:0035694) |
| 0.3 |
1.0 |
GO:0045046 |
protein import into peroxisome membrane(GO:0045046) |
| 0.3 |
1.6 |
GO:0045229 |
cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.3 |
0.6 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.3 |
21.1 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.3 |
0.6 |
GO:0055083 |
monovalent inorganic anion homeostasis(GO:0055083) |
| 0.3 |
1.9 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.3 |
1.3 |
GO:0044266 |
multicellular organismal protein catabolic process(GO:0044254) protein digestion(GO:0044256) multicellular organismal macromolecule catabolic process(GO:0044266) |
| 0.3 |
1.6 |
GO:0002778 |
antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
| 0.3 |
5.4 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.3 |
6.0 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.3 |
3.8 |
GO:0045745 |
positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.3 |
5.0 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
| 0.3 |
2.8 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.3 |
1.6 |
GO:0045337 |
geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
| 0.3 |
8.5 |
GO:0001573 |
ganglioside metabolic process(GO:0001573) |
| 0.3 |
4.7 |
GO:0006488 |
dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.3 |
2.8 |
GO:0022417 |
protein maturation by protein folding(GO:0022417) |
| 0.3 |
1.6 |
GO:0007210 |
serotonin receptor signaling pathway(GO:0007210) |
| 0.3 |
0.3 |
GO:0045226 |
extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.3 |
1.2 |
GO:0009298 |
GDP-mannose biosynthetic process(GO:0009298) |
| 0.3 |
1.5 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.3 |
0.3 |
GO:1902159 |
regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
| 0.3 |
2.4 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.3 |
3.0 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.3 |
1.2 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.3 |
2.4 |
GO:0045023 |
G0 to G1 transition(GO:0045023) |
| 0.3 |
1.5 |
GO:0046457 |
prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.3 |
4.2 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.3 |
3.6 |
GO:1900745 |
positive regulation of p38MAPK cascade(GO:1900745) |
| 0.3 |
1.5 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.3 |
2.1 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.3 |
1.2 |
GO:0051413 |
response to cortisone(GO:0051413) |
| 0.3 |
1.2 |
GO:0097211 |
response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.3 |
4.8 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.3 |
0.9 |
GO:0043084 |
penile erection(GO:0043084) |
| 0.3 |
1.8 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.3 |
1.2 |
GO:0019852 |
L-ascorbic acid metabolic process(GO:0019852) |
| 0.3 |
0.6 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.3 |
0.3 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.3 |
13.8 |
GO:0046839 |
phospholipid dephosphorylation(GO:0046839) |
| 0.3 |
5.5 |
GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
| 0.3 |
0.6 |
GO:0007320 |
insemination(GO:0007320) |
| 0.3 |
11.3 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.3 |
1.7 |
GO:0006850 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.3 |
0.9 |
GO:0060940 |
epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
| 0.3 |
1.4 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.3 |
4.0 |
GO:2001199 |
negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.3 |
1.4 |
GO:0034241 |
macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 0.3 |
2.3 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) positive regulation of adipose tissue development(GO:1904179) |
| 0.3 |
0.9 |
GO:0014736 |
negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
| 0.3 |
0.9 |
GO:0006863 |
purine nucleobase transport(GO:0006863) pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.3 |
3.7 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.3 |
0.3 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.3 |
0.3 |
GO:0061009 |
common bile duct development(GO:0061009) |
| 0.3 |
0.8 |
GO:0002604 |
regulation of dendritic cell antigen processing and presentation(GO:0002604) |
| 0.3 |
0.8 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.3 |
3.1 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.3 |
1.4 |
GO:0071043 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.3 |
0.6 |
GO:0001560 |
regulation of cell growth by extracellular stimulus(GO:0001560) |
| 0.3 |
1.7 |
GO:0006577 |
amino-acid betaine metabolic process(GO:0006577) |
| 0.3 |
0.6 |
GO:0046469 |
platelet activating factor metabolic process(GO:0046469) |
| 0.3 |
0.3 |
GO:1990314 |
cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.3 |
1.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.3 |
3.3 |
GO:1903831 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.3 |
3.0 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.3 |
1.1 |
GO:0046643 |
regulation of gamma-delta T cell activation(GO:0046643) |
| 0.3 |
2.2 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.3 |
0.8 |
GO:0061591 |
calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.3 |
0.8 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.3 |
1.3 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.3 |
1.3 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.3 |
3.0 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.3 |
1.1 |
GO:0014805 |
smooth muscle adaptation(GO:0014805) smooth muscle hyperplasia(GO:0014806) |
| 0.3 |
0.3 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.3 |
1.3 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.3 |
0.8 |
GO:0071529 |
cementum mineralization(GO:0071529) |
| 0.3 |
1.3 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.3 |
6.6 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.3 |
2.4 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
| 0.3 |
0.5 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.3 |
1.6 |
GO:0097267 |
omega-hydroxylase P450 pathway(GO:0097267) |
| 0.3 |
1.8 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.3 |
16.4 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.3 |
14.0 |
GO:0035082 |
axoneme assembly(GO:0035082) |
| 0.3 |
1.1 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.3 |
1.1 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.3 |
1.3 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 |
0.3 |
GO:1902667 |
regulation of axon guidance(GO:1902667) |
| 0.3 |
2.9 |
GO:0031284 |
positive regulation of guanylate cyclase activity(GO:0031284) |
| 0.3 |
7.3 |
GO:0016126 |
sterol biosynthetic process(GO:0016126) |
| 0.3 |
1.6 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.3 |
3.1 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.3 |
0.5 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.3 |
3.9 |
GO:0010829 |
negative regulation of glucose transport(GO:0010829) |
| 0.3 |
1.5 |
GO:0006382 |
adenosine to inosine editing(GO:0006382) |
| 0.3 |
0.5 |
GO:0044107 |
cellular alcohol metabolic process(GO:0044107) cellular alcohol biosynthetic process(GO:0044108) |
| 0.3 |
7.4 |
GO:0036151 |
phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.3 |
0.5 |
GO:0046125 |
thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.3 |
11.0 |
GO:0061098 |
positive regulation of protein tyrosine kinase activity(GO:0061098) |
| 0.3 |
1.8 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
| 0.3 |
0.8 |
GO:0098507 |
polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.3 |
0.8 |
GO:0072272 |
proximal/distal pattern formation involved in metanephric nephron development(GO:0072272) |
| 0.3 |
29.1 |
GO:0048813 |
dendrite morphogenesis(GO:0048813) |
| 0.3 |
14.2 |
GO:0001895 |
retina homeostasis(GO:0001895) |
| 0.3 |
1.3 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
| 0.3 |
2.5 |
GO:0006048 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.3 |
0.3 |
GO:1904779 |
regulation of protein localization to centrosome(GO:1904779) |
| 0.2 |
3.7 |
GO:1902074 |
response to salt(GO:1902074) |
| 0.2 |
3.0 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
0.7 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.2 |
6.7 |
GO:0008045 |
motor neuron axon guidance(GO:0008045) |
| 0.2 |
3.2 |
GO:0097354 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.2 |
12.8 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.2 |
0.2 |
GO:0021691 |
hindbrain maturation(GO:0021578) cerebellum maturation(GO:0021590) central nervous system maturation(GO:0021626) cerebellar Purkinje cell layer maturation(GO:0021691) cerebellar cortex maturation(GO:0021699) |
| 0.2 |
1.0 |
GO:1903173 |
phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 0.2 |
0.5 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.2 |
1.9 |
GO:0046398 |
UDP-glucuronate metabolic process(GO:0046398) |
| 0.2 |
0.2 |
GO:0019376 |
galactolipid catabolic process(GO:0019376) |
| 0.2 |
0.5 |
GO:0036269 |
swimming behavior(GO:0036269) |
| 0.2 |
4.1 |
GO:0007175 |
negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
| 0.2 |
1.4 |
GO:0098704 |
fructose transport(GO:0015755) fructose import(GO:0032445) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
| 0.2 |
1.0 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 0.2 |
1.4 |
GO:0071285 |
cellular response to lithium ion(GO:0071285) |
| 0.2 |
2.4 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.2 |
6.4 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.2 |
0.5 |
GO:0042659 |
regulation of cell fate specification(GO:0042659) |
| 0.2 |
0.5 |
GO:1903412 |
response to bile acid(GO:1903412) |
| 0.2 |
2.6 |
GO:0038065 |
collagen-activated signaling pathway(GO:0038065) |
| 0.2 |
0.2 |
GO:0042376 |
phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.2 |
1.2 |
GO:0036363 |
transforming growth factor beta activation(GO:0036363) |
| 0.2 |
5.2 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.2 |
5.2 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.2 |
0.7 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
2.1 |
GO:0086016 |
AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.2 |
0.7 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.2 |
2.8 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.2 |
0.9 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.2 |
1.6 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.2 |
9.5 |
GO:0045921 |
positive regulation of exocytosis(GO:0045921) |
| 0.2 |
1.2 |
GO:1900245 |
positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.2 |
0.9 |
GO:0006015 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.2 |
1.2 |
GO:0021888 |
hypothalamus gonadotrophin-releasing hormone neuron differentiation(GO:0021886) hypothalamus gonadotrophin-releasing hormone neuron development(GO:0021888) |
| 0.2 |
0.7 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.2 |
0.5 |
GO:1903336 |
negative regulation of vacuolar transport(GO:1903336) negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.2 |
23.2 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.2 |
4.5 |
GO:0033617 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) |
| 0.2 |
1.1 |
GO:1900273 |
positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.2 |
0.5 |
GO:0072112 |
renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) |
| 0.2 |
4.3 |
GO:0006450 |
regulation of translational fidelity(GO:0006450) |
| 0.2 |
0.9 |
GO:1901341 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 |
1.1 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.2 |
0.9 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.2 |
2.9 |
GO:0042355 |
fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.2 |
0.4 |
GO:0034227 |
tRNA thio-modification(GO:0034227) |
| 0.2 |
1.1 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.2 |
2.2 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.2 |
2.0 |
GO:0097338 |
response to clozapine(GO:0097338) |
| 0.2 |
0.7 |
GO:0032610 |
interleukin-1 alpha production(GO:0032610) |
| 0.2 |
2.0 |
GO:0006063 |
uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) |
| 0.2 |
0.9 |
GO:0009133 |
nucleoside diphosphate biosynthetic process(GO:0009133) |
| 0.2 |
1.1 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.2 |
0.7 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
| 0.2 |
1.9 |
GO:0042737 |
drug catabolic process(GO:0042737) |
| 0.2 |
0.6 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.2 |
2.6 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.2 |
6.4 |
GO:0060042 |
retina morphogenesis in camera-type eye(GO:0060042) |
| 0.2 |
0.6 |
GO:1903011 |
negative regulation of bone development(GO:1903011) |
| 0.2 |
5.1 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.2 |
3.2 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.2 |
6.1 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.2 |
1.7 |
GO:0090313 |
regulation of protein targeting to membrane(GO:0090313) |
| 0.2 |
0.8 |
GO:1990481 |
mRNA pseudouridine synthesis(GO:1990481) |
| 0.2 |
1.0 |
GO:0006702 |
androgen biosynthetic process(GO:0006702) |
| 0.2 |
0.6 |
GO:2000542 |
negative regulation of gastrulation(GO:2000542) |
| 0.2 |
7.3 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.2 |
6.7 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.2 |
1.0 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.2 |
4.8 |
GO:0016254 |
preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.2 |
3.5 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) glucosamine-containing compound catabolic process(GO:1901072) |
| 0.2 |
3.1 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.2 |
0.6 |
GO:0061051 |
positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
| 0.2 |
0.6 |
GO:1902410 |
mitotic cytokinetic process(GO:1902410) |
| 0.2 |
1.0 |
GO:0051383 |
kinetochore organization(GO:0051383) |
| 0.2 |
0.8 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.2 |
0.4 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.2 |
1.0 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.2 |
0.4 |
GO:0070343 |
white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.2 |
1.0 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.2 |
1.6 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.2 |
2.0 |
GO:0044065 |
regulation of respiratory system process(GO:0044065) |
| 0.2 |
1.4 |
GO:0042986 |
positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.2 |
3.0 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.2 |
1.8 |
GO:0060445 |
branching involved in salivary gland morphogenesis(GO:0060445) |
| 0.2 |
2.0 |
GO:0090382 |
phagosome maturation(GO:0090382) |
| 0.2 |
0.6 |
GO:0035865 |
cellular response to potassium ion(GO:0035865) |
| 0.2 |
0.8 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.2 |
3.2 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.2 |
1.4 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.2 |
0.8 |
GO:0018277 |
protein deamination(GO:0018277) |
| 0.2 |
3.4 |
GO:0003322 |
pancreatic A cell development(GO:0003322) |
| 0.2 |
0.8 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 0.2 |
11.4 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.2 |
20.2 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.2 |
1.8 |
GO:0045039 |
protein import into mitochondrial inner membrane(GO:0045039) |
| 0.2 |
9.2 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
| 0.2 |
1.0 |
GO:2000364 |
cardiac muscle tissue regeneration(GO:0061026) regulation of STAT protein import into nucleus(GO:2000364) positive regulation of STAT protein import into nucleus(GO:2000366) |
| 0.2 |
0.4 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.2 |
1.2 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.2 |
0.6 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.2 |
0.4 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.2 |
4.7 |
GO:0022011 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.2 |
2.5 |
GO:0033622 |
integrin activation(GO:0033622) |
| 0.2 |
0.2 |
GO:1903625 |
negative regulation of DNA catabolic process(GO:1903625) |
| 0.2 |
6.5 |
GO:0015949 |
nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.2 |
0.6 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.2 |
1.0 |
GO:1903564 |
regulation of protein localization to cilium(GO:1903564) |
| 0.2 |
3.8 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.2 |
1.5 |
GO:0097396 |
response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.2 |
1.3 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.2 |
0.4 |
GO:0015860 |
purine nucleoside transmembrane transport(GO:0015860) |
| 0.2 |
2.1 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.2 |
0.2 |
GO:2000510 |
positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.2 |
0.7 |
GO:0072217 |
negative regulation of metanephros development(GO:0072217) |
| 0.2 |
0.4 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.2 |
0.6 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.2 |
2.4 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 |
0.2 |
GO:0086067 |
AV node cell to bundle of His cell communication(GO:0086067) |
| 0.2 |
2.5 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.2 |
0.7 |
GO:0046603 |
negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.2 |
3.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
| 0.2 |
0.5 |
GO:0046146 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.2 |
2.0 |
GO:0090141 |
positive regulation of mitochondrial fission(GO:0090141) |
| 0.2 |
1.4 |
GO:0017062 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 0.2 |
0.7 |
GO:0044376 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 |
0.4 |
GO:0071639 |
positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
| 0.2 |
0.5 |
GO:1902202 |
regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
| 0.2 |
2.6 |
GO:0051256 |
mitotic spindle midzone assembly(GO:0051256) |
| 0.2 |
0.5 |
GO:0044878 |
abscission(GO:0009838) mitotic cytokinesis checkpoint(GO:0044878) |
| 0.2 |
1.6 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.2 |
1.2 |
GO:0001780 |
neutrophil homeostasis(GO:0001780) |
| 0.2 |
1.7 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.2 |
0.2 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.2 |
4.0 |
GO:2000169 |
regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
| 0.2 |
0.7 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.2 |
1.0 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 |
0.2 |
GO:0048265 |
response to pain(GO:0048265) |
| 0.2 |
18.6 |
GO:0006661 |
phosphatidylinositol biosynthetic process(GO:0006661) |
| 0.2 |
2.7 |
GO:0061684 |
chaperone-mediated autophagy(GO:0061684) |
| 0.2 |
0.3 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.2 |
11.5 |
GO:0006023 |
aminoglycan biosynthetic process(GO:0006023) |
| 0.2 |
0.7 |
GO:0044794 |
positive regulation by host of viral process(GO:0044794) |
| 0.2 |
1.2 |
GO:1900038 |
negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.2 |
0.7 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 |
1.2 |
GO:1903963 |
arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.2 |
2.0 |
GO:0048290 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
| 0.2 |
2.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.2 |
2.1 |
GO:0019388 |
galactose catabolic process(GO:0019388) |
| 0.2 |
1.1 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.2 |
1.8 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.2 |
2.3 |
GO:0090026 |
positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.2 |
0.6 |
GO:2000794 |
regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000794) |
| 0.2 |
0.2 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.2 |
1.0 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.2 |
1.0 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.2 |
1.1 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.2 |
1.4 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.2 |
0.5 |
GO:0030828 |
positive regulation of cGMP metabolic process(GO:0030825) positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.2 |
0.6 |
GO:0036017 |
response to erythropoietin(GO:0036017) |
| 0.2 |
2.8 |
GO:0098930 |
axonal transport(GO:0098930) |
| 0.2 |
1.2 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.2 |
0.6 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.2 |
1.7 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.2 |
1.2 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.2 |
2.4 |
GO:0045008 |
depyrimidination(GO:0045008) |
| 0.1 |
1.5 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.1 |
0.7 |
GO:0016137 |
glycoside metabolic process(GO:0016137) |
| 0.1 |
3.1 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 |
0.4 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 |
1.3 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.7 |
GO:0009223 |
pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
0.1 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
| 0.1 |
0.4 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.1 |
0.3 |
GO:0035864 |
response to potassium ion(GO:0035864) |
| 0.1 |
0.4 |
GO:0015781 |
pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.1 |
1.9 |
GO:0035268 |
protein mannosylation(GO:0035268) |
| 0.1 |
0.4 |
GO:0034141 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.1 |
1.6 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
| 0.1 |
0.4 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.1 |
0.4 |
GO:0090598 |
male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
| 0.1 |
0.3 |
GO:0050655 |
dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.1 |
0.7 |
GO:0043456 |
regulation of pentose-phosphate shunt(GO:0043456) |
| 0.1 |
5.2 |
GO:0042104 |
positive regulation of activated T cell proliferation(GO:0042104) |
| 0.1 |
0.1 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.1 |
0.9 |
GO:0042749 |
regulation of circadian sleep/wake cycle(GO:0042749) |
| 0.1 |
0.4 |
GO:0015722 |
canalicular bile acid transport(GO:0015722) |
| 0.1 |
2.0 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 |
0.9 |
GO:0001963 |
synaptic transmission, dopaminergic(GO:0001963) |
| 0.1 |
0.5 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.1 |
0.5 |
GO:0071397 |
cellular response to cholesterol(GO:0071397) |
| 0.1 |
0.1 |
GO:2000851 |
positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.1 |
1.7 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 |
0.1 |
GO:0006679 |
glucosylceramide biosynthetic process(GO:0006679) |
| 0.1 |
0.1 |
GO:1903939 |
regulation of TORC2 signaling(GO:1903939) |
| 0.1 |
3.0 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.1 |
0.4 |
GO:2001034 |
positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.1 |
1.2 |
GO:0018065 |
protein-cofactor linkage(GO:0018065) |
| 0.1 |
1.2 |
GO:0031646 |
positive regulation of neurological system process(GO:0031646) |
| 0.1 |
1.3 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 |
0.6 |
GO:0030204 |
chondroitin sulfate metabolic process(GO:0030204) |
| 0.1 |
1.3 |
GO:0032026 |
response to magnesium ion(GO:0032026) |
| 0.1 |
0.1 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.1 |
0.1 |
GO:0009074 |
aromatic amino acid family catabolic process(GO:0009074) |
| 0.1 |
0.1 |
GO:0015865 |
purine nucleotide transport(GO:0015865) |
| 0.1 |
0.3 |
GO:0008211 |
glucocorticoid metabolic process(GO:0008211) |
| 0.1 |
0.1 |
GO:1904478 |
regulation of intestinal absorption(GO:1904478) |
| 0.1 |
0.4 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.1 |
0.5 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.1 |
0.1 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 |
0.4 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.1 |
0.1 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.1 |
0.5 |
GO:0042133 |
neurotransmitter metabolic process(GO:0042133) |
| 0.1 |
0.6 |
GO:0042494 |
detection of bacterial lipoprotein(GO:0042494) |
| 0.1 |
0.7 |
GO:0035105 |
sterol regulatory element binding protein import into nucleus(GO:0035105) |
| 0.1 |
0.4 |
GO:0071922 |
establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 |
0.4 |
GO:0044857 |
plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
| 0.1 |
0.1 |
GO:1903430 |
negative regulation of cell maturation(GO:1903430) |
| 0.1 |
0.6 |
GO:0071163 |
DNA replication preinitiation complex assembly(GO:0071163) |
| 0.1 |
0.4 |
GO:0042853 |
L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.1 |
0.5 |
GO:0042357 |
thiamine diphosphate metabolic process(GO:0042357) |
| 0.1 |
1.2 |
GO:0061085 |
regulation of histone H3-K27 methylation(GO:0061085) |
| 0.1 |
0.1 |
GO:0010609 |
mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 0.1 |
1.5 |
GO:0006995 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
11.0 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.1 |
4.7 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
0.2 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.1 |
2.4 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.1 |
0.8 |
GO:0002254 |
kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
| 0.1 |
1.1 |
GO:0010447 |
response to acidic pH(GO:0010447) |
| 0.1 |
0.9 |
GO:2000042 |
negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.1 |
0.9 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 |
1.1 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 |
0.4 |
GO:0008207 |
C21-steroid hormone metabolic process(GO:0008207) |
| 0.1 |
0.4 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.1 |
0.7 |
GO:0034370 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) |
| 0.1 |
0.5 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.2 |
GO:0045851 |
pH reduction(GO:0045851) |
| 0.1 |
0.1 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.1 |
0.6 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.5 |
GO:0009226 |
nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.1 |
0.1 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.1 |
0.2 |
GO:0042364 |
water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.1 |
8.0 |
GO:0035308 |
negative regulation of protein dephosphorylation(GO:0035308) |
| 0.1 |
0.1 |
GO:0019836 |
hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.1 |
1.0 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 |
2.0 |
GO:0031069 |
hair follicle morphogenesis(GO:0031069) |
| 0.1 |
1.7 |
GO:0044458 |
motile cilium assembly(GO:0044458) |
| 0.1 |
1.0 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.1 |
0.3 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.1 |
0.2 |
GO:1902523 |
positive regulation of protein K63-linked ubiquitination(GO:1902523) |
| 0.1 |
0.6 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.1 |
1.0 |
GO:2000615 |
regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.1 |
0.9 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) |
| 0.1 |
4.2 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.1 |
0.1 |
GO:0060721 |
spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.1 |
0.1 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.1 |
1.7 |
GO:0033139 |
regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 0.1 |
0.2 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.1 |
0.6 |
GO:0048239 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 |
0.8 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
| 0.1 |
0.3 |
GO:0070525 |
tRNA threonylcarbamoyladenosine metabolic process(GO:0070525) |
| 0.1 |
0.3 |
GO:0006012 |
galactose metabolic process(GO:0006012) |
| 0.1 |
0.1 |
GO:0042711 |
maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 |
1.3 |
GO:0008340 |
determination of adult lifespan(GO:0008340) |
| 0.1 |
0.3 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.1 |
2.0 |
GO:0017156 |
calcium ion regulated exocytosis(GO:0017156) |
| 0.1 |
0.4 |
GO:0000730 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 |
0.3 |
GO:0072044 |
collecting duct development(GO:0072044) |
| 0.1 |
0.4 |
GO:1902990 |
mitotic telomere maintenance via semi-conservative replication(GO:1902990) |
| 0.1 |
0.8 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.1 |
0.3 |
GO:0061213 |
positive regulation of mesonephros development(GO:0061213) |
| 0.1 |
0.6 |
GO:0072383 |
plus-end-directed vesicle transport along microtubule(GO:0072383) |
| 0.1 |
0.4 |
GO:0038170 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.1 |
0.3 |
GO:0042758 |
long-chain fatty acid catabolic process(GO:0042758) |
| 0.1 |
6.0 |
GO:0006805 |
xenobiotic metabolic process(GO:0006805) |
| 0.1 |
0.5 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.2 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.1 |
0.7 |
GO:1902661 |
positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.1 |
0.7 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.4 |
GO:0010669 |
epithelial structure maintenance(GO:0010669) |
| 0.1 |
1.1 |
GO:2000095 |
regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
| 0.1 |
0.6 |
GO:0051415 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
0.3 |
GO:0045872 |
positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.1 |
0.3 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.1 |
0.2 |
GO:1902224 |
ketone body metabolic process(GO:1902224) |
| 0.1 |
0.2 |
GO:0050955 |
thermoception(GO:0050955) |
| 0.1 |
0.7 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.5 |
GO:0035521 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.8 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.1 |
0.8 |
GO:1901889 |
negative regulation of cell junction assembly(GO:1901889) |
| 0.1 |
0.5 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.1 |
0.3 |
GO:1990167 |
protein K27-linked deubiquitination(GO:1990167) |
| 0.1 |
0.1 |
GO:0002215 |
defense response to nematode(GO:0002215) |
| 0.1 |
9.2 |
GO:0030073 |
insulin secretion(GO:0030073) |
| 0.1 |
0.4 |
GO:0007567 |
parturition(GO:0007567) |
| 0.1 |
0.7 |
GO:0001953 |
negative regulation of cell-matrix adhesion(GO:0001953) |
| 0.1 |
0.1 |
GO:0048755 |
branching morphogenesis of a nerve(GO:0048755) |
| 0.1 |
0.3 |
GO:0010566 |
regulation of ketone biosynthetic process(GO:0010566) |
| 0.1 |
0.5 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.1 |
0.1 |
GO:0070358 |
actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 |
0.3 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) |
| 0.1 |
0.5 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.1 |
0.1 |
GO:0090197 |
positive regulation of chemokine secretion(GO:0090197) |
| 0.1 |
0.5 |
GO:0032218 |
riboflavin transport(GO:0032218) |
| 0.1 |
0.9 |
GO:0042551 |
neuron maturation(GO:0042551) |
| 0.1 |
0.4 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 |
0.2 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.1 |
0.1 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.1 |
0.1 |
GO:0060789 |
hair follicle placode formation(GO:0060789) |
| 0.1 |
0.1 |
GO:0097029 |
mature conventional dendritic cell differentiation(GO:0097029) |
| 0.1 |
0.5 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 |
0.3 |
GO:0050951 |
sensory perception of temperature stimulus(GO:0050951) |
| 0.1 |
0.3 |
GO:0036149 |
phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.1 |
0.5 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.1 |
0.2 |
GO:0046541 |
saliva secretion(GO:0046541) |
| 0.1 |
0.5 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.1 |
0.2 |
GO:0048670 |
regulation of collateral sprouting(GO:0048670) |
| 0.1 |
0.3 |
GO:0035932 |
mineralocorticoid secretion(GO:0035931) aldosterone secretion(GO:0035932) regulation of mineralocorticoid secretion(GO:2000855) regulation of aldosterone secretion(GO:2000858) |
| 0.1 |
0.1 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.1 |
0.7 |
GO:0048713 |
regulation of oligodendrocyte differentiation(GO:0048713) |
| 0.1 |
0.7 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
3.7 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.1 |
0.8 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.1 |
0.4 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.1 |
0.1 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) |
| 0.1 |
0.4 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.1 |
0.1 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.0 |
0.3 |
GO:0015824 |
proline transport(GO:0015824) |
| 0.0 |
4.4 |
GO:0007224 |
smoothened signaling pathway(GO:0007224) |
| 0.0 |
0.0 |
GO:0045713 |
low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
| 0.0 |
0.1 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.1 |
GO:0010966 |
regulation of phosphate transport(GO:0010966) |
| 0.0 |
1.1 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.0 |
0.2 |
GO:0016264 |
gap junction assembly(GO:0016264) |
| 0.0 |
0.0 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.0 |
0.5 |
GO:0034033 |
nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 |
0.1 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.0 |
0.3 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.0 |
0.1 |
GO:0021554 |
optic nerve development(GO:0021554) |
| 0.0 |
0.5 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.1 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.0 |
0.5 |
GO:1901678 |
iron coordination entity transport(GO:1901678) |
| 0.0 |
0.3 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.0 |
0.7 |
GO:0031268 |
pseudopodium organization(GO:0031268) |
| 0.0 |
0.0 |
GO:0046813 |
receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.0 |
0.4 |
GO:0035767 |
endothelial cell chemotaxis(GO:0035767) |
| 0.0 |
0.2 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.0 |
0.0 |
GO:0014827 |
intestine smooth muscle contraction(GO:0014827) |
| 0.0 |
0.4 |
GO:0010994 |
regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 0.0 |
3.7 |
GO:0070268 |
cornification(GO:0070268) |
| 0.0 |
0.1 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.0 |
0.1 |
GO:0061074 |
regulation of neural retina development(GO:0061074) |
| 0.0 |
0.2 |
GO:0021696 |
cerebellar cortex morphogenesis(GO:0021696) |
| 0.0 |
0.1 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.0 |
0.0 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.0 |
0.1 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.0 |
0.2 |
GO:1903025 |
regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
| 0.0 |
0.1 |
GO:0006868 |
glutamine transport(GO:0006868) |
| 0.0 |
0.2 |
GO:0070633 |
transepithelial chloride transport(GO:0030321) transepithelial transport(GO:0070633) |
| 0.0 |
0.2 |
GO:0002638 |
negative regulation of immunoglobulin production(GO:0002638) |
| 0.0 |
0.6 |
GO:0046949 |
fatty-acyl-CoA biosynthetic process(GO:0046949) |
| 0.0 |
3.8 |
GO:0071804 |
cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
| 0.0 |
5.1 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
| 0.0 |
0.1 |
GO:0090201 |
negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.0 |
0.3 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.0 |
0.1 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 |
0.1 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.0 |
0.0 |
GO:1902299 |
pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.0 |
0.1 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.0 |
0.2 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.0 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.0 |
0.4 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.0 |
0.1 |
GO:0030043 |
actin filament fragmentation(GO:0030043) |
| 0.0 |
0.3 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.1 |
GO:0097475 |
motor neuron migration(GO:0097475) |
| 0.0 |
0.0 |
GO:0006623 |
protein targeting to vacuole(GO:0006623) |
